RMFCX
Price
$55.64
Change
-$3.00 (-5.12%)
Updated
Dec 17 closing price
VYCGX
Price
$24.52
Change
-$0.12 (-0.49%)
Updated
Dec 17 closing price
Ad is loading...

RMFCX vs VYCGX

Header iconRMFCX vs VYCGX Comparison
Open Charts RMFCX vs VYCGXBanner chart's image
American Funds American Mutual R3
Price$55.64
Change-$3.00 (-5.12%)
VolumeN/A
CapitalizationN/A
Voya Corporate Leaders 100 R6
Price$24.52
Change-$0.12 (-0.49%)
VolumeN/A
CapitalizationN/A
RMFCX vs VYCGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
RMFCX vs. VYCGX commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RMFCX is a Buy and VYCGX is a Buy.

FUNDAMENTALS
Fundamentals
RMFCX has more cash in the bank: 104B vs. VYCGX (1.12B). RMFCX (1.69) and VYCGX (1.65) have matching dividends . RMFCX was incepted earlier than VYCGX: RMFCX (23 years) vs VYCGX (10 years). VYCGX is a more actively managed with annual turnover of: 29.00 vs. RMFCX (25.00). RMFCX has a lower initial minimum investment than VYCGX: RMFCX (250) vs VYCGX (1000000). VYCGX annual gain was more profitable for investors over the last year : 15.62 vs. RMFCX (12.63). RMFCX return over 5 years is better than : 40.39 vs. VYCGX (24.23).
RMFCXVYCGXRMFCX / VYCGX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence23 years10 years-
Gain YTD11.42314.53779%
Front LoadN/AN/A-
Min. Initial Investment25010000000%
Min. Initial Investment IRAN/AN/A-
Net Assets104B1.12B9,286%
Annual Yield % from dividends1.691.65103%
Returns for 1 year12.6315.6281%
Returns for 3 years14.1617.0983%
Returns for 5 years40.3924.23167%
Returns for 10 years61.8458.72105%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
REKR0.83N/A
-0.01%
Rekor Systems
CRBG29.99-0.44
-1.45%
Corebridge Financial
WHD61.48-1.46
-2.32%
Cactus
ABCL2.79-0.07
-2.45%
AbCellera Biologics
TRIB0.85-0.05
-5.67%
Trinity Biotech plc